Agent Capital related stories
All articles and analysis
Precision BioScience snags $110 mln Series BDurham, North Carolina-based Precision BioScience, a genome editing system provider, has raised $110 million in Series B financing. ArrowMark Partners led the round with participation from other investors that included Franklin Templeton Investments, Cowen Healthcare Investments, Brace Pharma Capital, Adage Capital Management, Cormorant Asset Management, Gilead Sciences, Vivo Capital, Alexandria Venture Investments, Ridgeback Capital, Agent Capital, Leerink Partners, venBio, F-Prime and Osage University Partners.
- Carisma Therapeutics inks $53 mln Series A
Philadelphia-based Carisma Therapeutics Inc, a developer of macrophage-based immunotherapeutics, has raised $53 million in Series A financing. AbbVie Ventures and HealthCap led the round with participation from other investors that included IP Group, Penn Medicine, Grazia Equity, Wellington Partners, TPG Biotech, MRL Ventures Fund and Agent Capital.
- Skyhawk Therapeutics lands $40 mln
Waltham, Massachusetts-based Skyhawk Therapeutics Inc, a developer of small molecule therapeutics that correct RNA expression, has secured $40 million in funding. The company's investors include Alexandria Venture Investments, GreatPoint Ventures, ShangPharma Innovation and Agent Capital.
- Agent Capital collects $57.75 mln for $150 mln-targeted fund
Cambridge, Massachusetts-based Agent Capital, a biotech-focused venture firm, has raised $57.75 million for its initial fund, according to an SEC filing https://www.sec.gov/Archives/edgar/data/1706036/000170603618000003/xslFormDX01/primary_doc.xml The target is $150 million.
- Agent Capital raises $52 mln for maiden venture capital fund
Agent Capital has raised $52 million for a maiden venture capital fund, according to a filing with the SEC.
- Aptinyx lands $70 mln Series B
Aptinyx Inc, a developer of treatments for neurologic disorders, has closed $70 million in Series B financing. Bain Capital Life Sciences led the round with participation from other investors that included Adage Capital, Agent Capital, HBM Healthcare Investments, Nan Fung Life Sciences, Partner Fund Management, Rock Springs Capital, New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners and Beecken Petty O'Keefe & Company.
- Agent Capital raises $25m
View the latest capital raises